Enhanced sensitivity for AKT inhibition under hypoxia was observed in part of HNSCC and NSCLC lines, irrespective of the effect of AKT inhibition on hypoxic HIF-1 signaling. The gene discussed is HIF1A; the disease is non-small cell lung carcinoma.